CIK: 0001839435 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $642,220 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 3,160,000 | $163,404 | 25.4% | $48.04 | +10.4% | COM | 03753U106 |
| — | CHINOOK THERAPEUTICS INC | 2,551,703 | $66,855 | 10.4% | $16.88 | — | COM | 16961L106 |
| — | VERONA PHARMA PLC | 2,468,000 | $64,489 | 10.0% | $17.59 | — | SPONSORED ADS | 925050106 |
| RCUS | ARCUS BIOSCIENCES INC | 2,482,700 | $51,342 | 8.0% | $33.27 | -17.3% | COM | 03969F109 |
| — | MIRATI THERAPEUTICS INC | 750,000 | $33,983 | 5.3% | $52.54 | — | COM | 60468T105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 761,398 | $33,936 | 5.3% | $25.60 | +39.5% | COM NEW | 15117B202 |
| — | IVERIC BIO INC | 1,278,000 | $27,362 | 4.3% | $21.41 | — | COM | 46583P102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 824,200 | $24,075 | 3.7% | $23.04 | 0.0% | COM | 92790C104 |
| TNDM | TANDEM DIABETES CARE INC | 474,929 | $21,348 | 3.3% | $54.82 | -17.4% | COM NEW | 875372203 |
| — | AEROVATE THERAPEUTICS INC | 621,712 | $18,216 | 2.8% | $29.30 | — | COM | 008064107 |
| XBI | SPDR SER TR | 199,417 | $16,552 | 2.6% | $77.85 | — | S&P BIOTECH | 78464A870 |
| VERA | VERA THERAPEUTICS INC | 665,156 | $12,871 | 2.0% | $16.05 | +12.8% | CL A | 92337R101 |
| — | INTRA-CELLULAR THERAPIES INC | 220,953 | $11,693 | 1.8% | $46.53 | — | COM | 46116X101 |
| — | CYMABAY THERAPEUTICS INC | 1,859,200 | $11,657 | 1.8% | $6.27 | — | COM | 23257D103 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 499,996 | $11,105 | 1.7% | $30.23 | -48.9% | COM | 35104E100 |
| — | ALPINE IMMUNE SCIENCES INC | 1,225,000 | $9,004 | 1.4% | $7.20 | — | COM | 02083G100 |
| — | ITEOS THERAPEUTICS INC | 445,000 | $8,691 | 1.4% | $19.53 | — | COM | 46565G104 |
| VKTX | VIKING THERAPEUTICS INC | 870,500 | $8,183 | 1.3% | $4.46 | 0.0% | COM | 92686J106 |
| RNAM | AVIDITY BIOSCIENCES INC | 324,629 | $7,204 | 1.1% | $27.48 | -45.7% | COM | 05370A108 |
| BBIO | BRIDGEBIO PHARMA INC | 933,743 | $7,115 | 1.1% | $38.67 | -75.2% | COM | 10806X102 |
| STOK | STOKE THERAPEUTICS INC | 763,456 | $7,047 | 1.1% | $27.91 | -62.7% | COM | 86150R107 |
| XLO | XILIO THERAPEUTICS INC | 2,425,000 | $6,523 | 1.0% | $2.77 | -13.1% | COM | 98422T100 |
| — | 89BIO INC | 380,000 | $4,837 | 0.8% | $12.73 | — | COM | 282559103 |
| GOSS | GOSSAMER BIO INC | 1,958,069 | $4,249 | 0.7% | $9.60 | -14.2% | COM | 38341P102 |
| MIRM | MIRUM PHARMACEUTICALS INC | 100,000 | $1,950 | 0.3% | $24.08 | -17.9% | COM | 604749101 |
| — | PRAXIS PRECISION MEDICINES I | 800,000 | $1,904 | 0.3% | $2.38 | — | COM | 74006W108 |
| DXCM | DEXCOM INC | 15,000 | $1,699 | 0.3% | $84.70 | +29.6% | COM | 252131107 |
| — | PROMETHEUS BIOSCIENCES INC | 15,000 | $1,650 | 0.3% | $110.00 | — | COM | 74349U108 |
| — | JOUNCE THERAPEUTICS INC | 1,400,000 | $1,554 | 0.2% | $2.34 | — | COM | 481116101 |
| MREO | MEREO BIOPHARMA GROUP PLC | 1,000,000 | $750 | 0.1% | $1.12 | — | SPON ADS | 589492107 |
| NUVL | NUVALENT INC | 25,000 | $745 | 0.1% | $16.74 | +66.6% | COM | 670703107 |
| IPSC | CENTURY THERAPEUTICS INC | 45,000 | $231 | 0.0% | $24.92 | -62.1% | COM | 15673T100 |